Filtros de búsqueda

Lista de obras de Norbert Pardi

2772. HCMV gB Ectodomain Subunit and gB mRNA Vaccines Reduce AD-3 Immunodominance and Elicit More Durable Antibody Responses Than gB/MF59 Immunization

artículo científico publicado en 2019

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

scientific article published on 19 April 2020

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

scientific article published on 30 July 2020

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

artículo científico publicado en 2017

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

artículo científico publicado en 2020

Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria

scientific article published on 22 April 2020

Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques

article

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

artículo científico publicado en 2020

Daxx-like protein of Drosophila interacts with Dmp53 and affects longevity and Ark mRNA level.

artículo científico publicado en 2007

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

artículo científico publicado en 2015

HCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization

artículo científico publicado en 2020

HPLC purification of in vitro transcribed long RNA.

artículo científico publicado en 2013

In vitro transcription of long RNA containing modified nucleosides

artículo científico publicado en 2013

In vivo effects of abolishing the single canonical sumoylation site in the C-terminal region of Drosophila p53.

artículo científico publicado en 2011

Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization

artículo científico publicado en 2017

Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

artículo científico publicado en 2020

Measuring the Adjuvant Activity of RNA Vaccines

artículo científico publicado en 2017

Messenger RNA-Based Vaccines Against Infectious Diseases

scientific article published on 17 April 2020

New Kids on the Block: RNA-Based Influenza Virus Vaccines.

artículo científico publicado en 2018

Nucleoside Modified mRNA Vaccines for Infectious Diseases

artículo científico publicado en 2017

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

artículo científico publicado en 2019

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

artículo científico publicado en 2018

Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice

artículo científico publicado en 2020

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

artículo científico publicado en 2018

PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake

artículo científico publicado en 2018

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine

artículo científico publicado en 2020

Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response

artículo científico publicado en 2018

Recent advances in mRNA vaccine technology

scientific article published on 31 March 2020

SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation

scientific article published on 21 November 2020

Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier

scientific article published on 31 January 2020

TATA binding protein associated factor 3 (TAF3) interacts with p53 and inhibits its function

artículo científico publicado en 2008

The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans

scientific article published on 22 April 2020

Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination

artículo científico publicado en 2021

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

artículo científico publicado en 2017

mRNA vaccines - a new era in vaccinology

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda